SAB Biotherapeutics (SABS) Preferred Shares (2023 - 2026)
SAB Biotherapeutics (SABS) posted Preferred Shares of $59.0 for Q1 2026, down 7.81% on a QoQ basis from $64.0 in Q4 2025, and up 1080.0% year-over-year from $5.0 in Q1 2025.
SAB Biotherapeutics (SABS) Preferred Shares (2023 - 2026) Analysis & Trends
SAB Biotherapeutics' Preferred Shares history runs 4 years deep, the most recent figure standing at $59.0 for Q1 2026.
- Quarterly Preferred Shares rose 1080.0% year-over-year to $59.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.0 (up 1080.0% YoY) and the FY2025 annual result came in at $64.0, changed N/A from the prior year.
- Preferred Shares was $59.0 for Q1 2026 at SAB Biotherapeutics, down from $64.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $64.0 in Q4 2025 and bottomed at $3.0 in Q3 2025.
- A 4-year average of $17.33 and a median of $5.0 in 2023 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2025 — Preferred Shares tumbled 40.0% — and 2026, when it surged 1080.0%.
- SAB Biotherapeutics' Preferred Shares stood at $5.0 in 2023, then changed by 0.0% to $5.0 in 2024, then jumped by 1180.0% to $64.0 in 2025, then declined by 7.81% to $59.0 in 2026.
- Business Quant data shows SABS's Preferred Shares at $59.0 in Q1 2026, $64.0 in Q4 2025, and $3.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | 59.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.00 |
| Dec 31, 2025 | 64.00 |
| Sep 30, 2025 | 3.00 |
| Jun 30, 2025 | 5.00 |
| Mar 31, 2025 | 5.00 |
| Sep 30, 2024 | 5.00 |
| Jun 30, 2024 | 5.00 |
| Mar 31, 2024 | 5.00 |
| Dec 31, 2023 | 5.00 |